ChiCTR2100049663
Untitled Trial
Evaluation of clinical efficacy of traditional Chinese medicine in promoting nucleic acid conversion of new coronavirus Delta variant strain infection
Guangdong Provincial Hospital of Chinese Medicine·Chinese Clinical Trial RegistryNot yet recruiting
View on Chinese Clinical Trial Registry →Study focus
- Disease/Condition
- Novel Coronavirus Pneumonia (COVID 19)
Sponsor & location
- Primary sponsor
- Guangdong Provincial Hospital of Chinese Medicine
- Funder
- National Administration of Traditional Chinese Medicine
- Location
- China
Timeline & enrollment
- Phase
- N/A
- Start date
- N/A
- End date
- Dec 31, 2022
ICD-10 classifications
COVID-19, virus identifiedViral pneumonia, unspecifiedOther viral pneumoniaCOVID-19, virus not identifiedPneumonia in viral diseases classified elsewhere
Data source
- Registry
- Chinese Clinical Trial Registry
- Trial ID
- ChiCTR2100049663
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for ChiCTR2100049663 through Pure Global AI's free database. This phase not specified trial is sponsored by Guangdong Provincial Hospital of Chinese Medicine and is currently Not yet recruiting. The study focuses on Novel Coronavirus Pneumonia (COVID 19).
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Chinese Clinical Trial Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.